Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

PartnershipPositive

AI Analysis

Summary

Medicines Discovery Catapult provided investment and expert support to two U.K. biotech companies, including TRAX, to accelerate development of treatments for autoimmune, inflammatory, and age-related diseases.

Importance:3/10

Sentiment:

0.50

partnershipinvestmentuk_biotechautoimmuneinflammatoryage-related_diseases

Related Companies

$TRAX

Read the original article

Published by GEN - Genetic Engineering & Biotech News on September 4, 2026 5:28 PM

Read Original